
Rei Tsang Shiao
Examiner (ID: 13461, Phone: (571)272-0707 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1626, 1628, 1629, 1691 |
| Total Applications | 3000 |
| Issued Applications | 2172 |
| Pending Applications | 215 |
| Abandoned Applications | 676 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7784794
[patent_doc_number] => 20120046350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-23
[patent_title] => 'NOVEL COMPOUNDS, THEIR PREPARATION AND USE'
[patent_app_type] => utility
[patent_app_number] => 12/689014
[patent_app_country] => US
[patent_app_date] => 2010-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19811
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20120046350.pdf
[firstpage_image] =>[orig_patent_app_number] => 12689014
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/689014 | NOVEL COMPOUNDS, THEIR PREPARATION AND USE | Jan 17, 2010 | Abandoned |
Array
(
[id] => 8955948
[patent_doc_number] => 08501721
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-06
[patent_title] => 'Postprandial hyperglycemia-improving agent'
[patent_app_type] => utility
[patent_app_number] => 13/144551
[patent_app_country] => US
[patent_app_date] => 2010-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3620
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13144551
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/144551 | Postprandial hyperglycemia-improving agent | Jan 14, 2010 | Issued |
Array
(
[id] => 9166786
[patent_doc_number] => 08592464
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-26
[patent_title] => 'Nitric oxide furoxan derivative compounds endowed with antitumoral activity'
[patent_app_type] => utility
[patent_app_number] => 13/144389
[patent_app_country] => US
[patent_app_date] => 2010-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4904
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13144389
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/144389 | Nitric oxide furoxan derivative compounds endowed with antitumoral activity | Jan 14, 2010 | Issued |
Array
(
[id] => 8875919
[patent_doc_number] => 08470885
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-25
[patent_title] => 'Composition and method for treatment of diabetes'
[patent_app_type] => utility
[patent_app_number] => 13/143766
[patent_app_country] => US
[patent_app_date] => 2010-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5467
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13143766
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/143766 | Composition and method for treatment of diabetes | Jan 10, 2010 | Issued |
Array
(
[id] => 6323030
[patent_doc_number] => 20100113756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'LUMINESCENT METAL COMPLEXES FOR MONITORING RENAL FUNCTION'
[patent_app_type] => utility
[patent_app_number] => 12/683851
[patent_app_country] => US
[patent_app_date] => 2010-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 8543
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20100113756.pdf
[firstpage_image] =>[orig_patent_app_number] => 12683851
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/683851 | LUMINESCENT METAL COMPLEXES FOR MONITORING RENAL FUNCTION | Jan 6, 2010 | Abandoned |
Array
(
[id] => 8538423
[patent_doc_number] => 08314144
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-20
[patent_title] => 'Compounds having antitumor activity'
[patent_app_type] => utility
[patent_app_number] => 12/683870
[patent_app_country] => US
[patent_app_date] => 2010-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4284
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12683870
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/683870 | Compounds having antitumor activity | Jan 6, 2010 | Issued |
Array
(
[id] => 7651913
[patent_doc_number] => 20110301182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => 'Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy comprising a DPP-IV inhibitor'
[patent_app_type] => utility
[patent_app_number] => 13/143370
[patent_app_country] => US
[patent_app_date] => 2010-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12607
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0301/20110301182.pdf
[firstpage_image] =>[orig_patent_app_number] => 13143370
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/143370 | Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy comprising a DPP-IV inhibitor | Jan 6, 2010 | Issued |
Array
(
[id] => 8944110
[patent_doc_number] => 08497289
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-30
[patent_title] => '3.1.0 bicyclic GlyT1 inhibitors and methods of making and using same'
[patent_app_type] => utility
[patent_app_number] => 12/648972
[patent_app_country] => US
[patent_app_date] => 2009-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33297
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12648972
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/648972 | 3.1.0 bicyclic GlyT1 inhibitors and methods of making and using same | Dec 28, 2009 | Issued |
Array
(
[id] => 7767973
[patent_doc_number] => 20120035163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-09
[patent_title] => 'NOVEL FUSED RING COMPOUND AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/142507
[patent_app_country] => US
[patent_app_date] => 2009-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60170
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20120035163.pdf
[firstpage_image] =>[orig_patent_app_number] => 13142507
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/142507 | Fused ring compound and use thereof | Dec 27, 2009 | Issued |
Array
(
[id] => 8721336
[patent_doc_number] => 20130072553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-21
[patent_title] => 'DRUGS, DERIVATIVES AND ANALOGS CONTAINING ADAMANTANE STRUCTURES OF NEW INDICATION APPLICATIONS OF ANTI-TUMOR'
[patent_app_type] => utility
[patent_app_number] => 13/376155
[patent_app_country] => US
[patent_app_date] => 2009-12-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4969
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13376155
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/376155 | DRUGS, DERIVATIVES AND ANALOGS CONTAINING ADAMANTANE STRUCTURES OF NEW INDICATION APPLICATIONS OF ANTI-TUMOR | Dec 24, 2009 | Abandoned |
Array
(
[id] => 6426158
[patent_doc_number] => 20100168178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'Stable insecticide compositions and methods for producing same'
[patent_app_type] => utility
[patent_app_number] => 12/653996
[patent_app_country] => US
[patent_app_date] => 2009-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18052
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20100168178.pdf
[firstpage_image] =>[orig_patent_app_number] => 12653996
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/653996 | Stable insecticide compositions and methods for producing same | Dec 21, 2009 | Issued |
Array
(
[id] => 6498007
[patent_doc_number] => 20100094017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'USING ALKYLMETAL REAGENTS FOR DIRECTED METALATION OF AZAAROMATICS'
[patent_app_type] => utility
[patent_app_number] => 12/641691
[patent_app_country] => US
[patent_app_date] => 2009-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3860
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20100094017.pdf
[firstpage_image] =>[orig_patent_app_number] => 12641691
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/641691 | USING ALKYLMETAL REAGENTS FOR DIRECTED METALATION OF AZAAROMATICS | Dec 17, 2009 | Abandoned |
Array
(
[id] => 8701635
[patent_doc_number] => 08394857
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-12
[patent_title] => '1-amino-alkylcyclohexane derivatives for the treatment of inflammatory skin diseases'
[patent_app_type] => utility
[patent_app_number] => 12/653865
[patent_app_country] => US
[patent_app_date] => 2009-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14997
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12653865
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/653865 | 1-amino-alkylcyclohexane derivatives for the treatment of inflammatory skin diseases | Dec 17, 2009 | Issued |
Array
(
[id] => 8630008
[patent_doc_number] => 08362080
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-29
[patent_title] => 'Increasing glutathione levels for therapy'
[patent_app_type] => utility
[patent_app_number] => 12/641894
[patent_app_country] => US
[patent_app_date] => 2009-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 49
[patent_no_of_words] => 14600
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12641894
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/641894 | Increasing glutathione levels for therapy | Dec 17, 2009 | Issued |
Array
(
[id] => 6638361
[patent_doc_number] => 20100173939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'ANTIVIRAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/639404
[patent_app_country] => US
[patent_app_date] => 2009-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22012
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20100173939.pdf
[firstpage_image] =>[orig_patent_app_number] => 12639404
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/639404 | ANTIVIRAL COMPOUNDS | Dec 15, 2009 | Abandoned |
Array
(
[id] => 6497971
[patent_doc_number] => 20100094012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'Heterodiamondoids'
[patent_app_type] => utility
[patent_app_number] => 12/637605
[patent_app_country] => US
[patent_app_date] => 2009-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 21429
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20100094012.pdf
[firstpage_image] =>[orig_patent_app_number] => 12637605
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/637605 | Heterodiamondoids | Dec 13, 2009 | Issued |
Array
(
[id] => 4596349
[patent_doc_number] => 07981975
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-07-19
[patent_title] => 'Heterodiamondoids'
[patent_app_type] => utility
[patent_app_number] => 12/637621
[patent_app_country] => US
[patent_app_date] => 2009-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 63
[patent_no_of_words] => 21451
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/981/07981975.pdf
[firstpage_image] =>[orig_patent_app_number] => 12637621
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/637621 | Heterodiamondoids | Dec 13, 2009 | Issued |
Array
(
[id] => 6038410
[patent_doc_number] => 20110091459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-21
[patent_title] => 'IMIDAZOLE MODULATORS OF MUSCARINIC ACETYLCHOLINE RECEPTOR M3'
[patent_app_type] => utility
[patent_app_number] => 12/635944
[patent_app_country] => US
[patent_app_date] => 2009-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10346
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20110091459.pdf
[firstpage_image] =>[orig_patent_app_number] => 12635944
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/635944 | IMIDAZOLE MODULATORS OF MUSCARINIC ACETYLCHOLINE RECEPTOR M3 | Dec 10, 2009 | Abandoned |
Array
(
[id] => 8807865
[patent_doc_number] => 08445517
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-21
[patent_title] => 'Stat modulators'
[patent_app_type] => utility
[patent_app_number] => 12/653342
[patent_app_country] => US
[patent_app_date] => 2009-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 25801
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12653342
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/653342 | Stat modulators | Dec 10, 2009 | Issued |
Array
(
[id] => 6362069
[patent_doc_number] => 20100087669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-08
[patent_title] => 'NOVEL PHENYLBORONIC ACID COMPOUNDS AND INTERMEDIATES AND PROCESSES FOR THE PREPARATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/635299
[patent_app_country] => US
[patent_app_date] => 2009-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4899
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20100087669.pdf
[firstpage_image] =>[orig_patent_app_number] => 12635299
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/635299 | NOVEL PHENYLBORONIC ACID COMPOUNDS AND INTERMEDIATES AND PROCESSES FOR THE PREPARATION THEREOF | Dec 9, 2009 | Abandoned |